Role of Hemogram-Derived Ratios and Systemic-Immune Inflammation Index in Prediction of COVID-19 Progression in Egyptian Patients

INTRODUCTION

Fatal coronavirus, named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has caused novel corona virus disease (COVID-19) which first broke out in December 2019 in Wuhan, China [1]. Fever, dry cough, and fatigue are the main manifestations of COVID-19. In more severe cases, patients often have dyspnea and/or hypoxemia that can rapidly progress to acute respiratory distress syndrome, septic shock, metabolic acidosis, coagulation dysfunction, and multiple organ failure [2].

Although the majority of COVID-19 patients have been classified as mild cases that can recover shortly after appropriate clinical intervention, rapid severe progression of the disease can occur with increasing rates of hospitalization, ICU admission and mortality [3]. Furthermore, not all COVID-19 patients have symptoms in the early stage of the disease, making early tracking of suspected cases very important [4]. Neither the detection capability of viral nucleic acid kits nor the popular rate of pulmonary imaging can support large-scale screening of all populations. In the current novel corona virus pandemic, if the most routine and inexpensive peripheral blood tests have characteristic changes for infected patients, especially those with severe infections, they will be very helpful for proper early clinical intervention to reduce the mortality of patients. Complete blood count (CBC) is the most widely performed, cost effective test that can be performed in almost all laboratories, even in those with limited equipment [4].

In this study, the role of peripheral CBC derived biomarkers (NLR, PLR, SII) together with the CRP at hospital admission, has been examined to predict the progression and the outcome of COVID-19 infection in a cohort of Egyptian patients.

MATERIALS AND METHODS

RESULTS

Prediction of disease severity, ICU admission and in-hospital mortality

Table 4 shows the independent prediction ability of the studied biomarkers and the optimal cut-off values calculated by the ROC analysis. As regards COVID-19 severity prediction, CRP AUC was 0.707 with a cut off value of 12 mg/L, sensitivity of 65.66% and specificity of 69.31%, followed by NLR, SII and PLR with AUC of 0.700, 0.669 and 0.640, and cut-off values of 4.33, 1012.36 and 185, respectively. Regarding ICU admission prediction, CRP AUC was 0.763 with a cut off value of 115 mg/L, sensitivity of 54.76% and specificity of 94.30%., followed by NLR, SII and PLR with AUC of 0.727, 0.717 and 0.580, and cut-off values of 4.5, 668.57 and 300, respectively. For in-hospital mortality prediction, CRP AUC was 0.812 with a cut off value of 141 mg/L, sensitivity of 70% and specificity of 95.56%, followed by NLR with AUC of 0.751 and a cut off value of 4.5. Figures 1-3

View this table:

• View inline
• View popup
• Download powerpoint

Table 4:

Recommended cut-off values for the prediction of COVID-19 severity, need for ICU admission and in-hospital mortality.

• Download figure
• Open in new tab

Figure 1:

Receiver-operating characteristic curve for prediction of disease severity

• Download figure
• Open in new tab

Figure 2:

Receiver-operating characteristic curve for prediction of ICU admission

• Download figure
• Open in new tab

Figure 3:

Receiver-operating characteristic curve for prediction of in-hospital mortality

DISCUSSION

Since hyper-inflammatory state has been incriminated in the patho-physiology of COVID-19, information about inflammation and the immune response of patients with different disease severity should be continuously explored for predicting the progression of the disease and improving the outcome of patients [1]. Complete blood counts are the most easily performed tests in a time and cost-effective manner. Included in the CBC are values that can be used as effective inflammatory biomarkers [4].

Neutrophils can be triggered by virus-related inflammatory factors to release large amounts of reactive oxygen species and other cytotoxic mediators, which may dampen the virus. Moreover, neutrophils are able to release neutrophil extracellular traps that help in capturing and damaging different pathogens, including viruses [6].

On the other hand, severe cases of viral infection can result in lymphocyte exhaustion, because viruses can directly attack and damage target cells; also, they can activate immune cells to participate in the anti-viral process, resulting in severe lymphocyte damage and apoptosis. Because systemic inflammation stimulates neutrophil production and accelerates lymphocyte apoptosis, virus-triggered inflammation raises the NLR ratio [6].

Additionally, as platelets have an important role in the regulation of various inflammatory processes, both the NLR and PLR indirectly reflect a patient’s inflammatory state [7]. In recent years, NLR and PLR have been validated as prognostic biomarkers in various disorders including cardiac conditions, solid tumors, sepsis, pneumonia, and acute respiratory distress syndrome [8].

A recently proposed score is the SII, which is an index defining the instability in the inflammatory response. SII has been proposed as a prognostic indicator in the follow-up of patients with sepsis and in a number of tumors including small cell lung and hepatocellular carcinomas [7].

The current study is aimed at exploring the role of NLR, PLR, and SII, in addition to the CRP in predicting severity of the disease, the need for ICU admission and in-hospital mortality in COVID-19 patients.

We found a significant relation between advancing patients’ ages and the severity of the disease as well as the rate of ICU admission and in-hospital mortality. However, these could not be linked to a specific gender. Our findings were consistent with the studies of Yang et al. and Fois et al. [4],[9], who reported significantly advanced age and non-significant difference in gender in the more severe cases and the non-survivors, respectively. However, our study was only partially consistent with Wang and colleagues [10] who reported non-significant differences in age or gender with the progression of the disease. Similar to the study of Yang et al. [4], we found the overall incidence of co-morbidities (diabetes, hypertension, kidney dysfunction) to be significantly higher in the more severe cases. However, partially contrary to the study of Fois et al. [9], who found only a significant association between heart disease and COVID-19 mortality and a non-significant association between disease mortality and the other co-morbidities including smoking, diabetes, and kidney disease, we found that in-hospital disease mortality was significantly higher in patients with diabetes, hypertension, kidney and heart diseases.

Our study also showed a significant increase in NLR, PLR, SII, and CRP in the more severe cases and in those who required ICU admission. However, only NLR and CRP were significantly elevated in patients who died from the disease. This was in accordance with the study of Yang and colleagues [4] who reported higher NLR, PLR and CRP in the more severe cases of the disease. However, partially consistent with our study, Fois and colleagues [9] reported significant elevation in NLR and SII in the non-survivor group of the disease; they also reported that SII might specifically reflect the pulmonary damage occurring in COVID-19 patients.

Our study revealed that the best cut-off points to predict disease severity and the need for ICU admission were, CRP > 12mg/l & > 115mg/l, NLR > 4.33 & > 4.5, SII > 1012.36 & > 668.57, and PLR > 185 & > 300, respectively. Also, the best cut-off points to predict in-hospital mortality were CRP > 145mg/l and NLR > 4.5. In view of our data, 4 of the 188 included mild cases required ICU admission during their hospital stay. This resulted in lowering the SII cut-off point of the need for ICU admission prediction compared to that used to predict the disease severity. Furthermore, by multivariate regression analysis, the SII was the best independent biomarker associated with disease severity; CRP and NLR were the best independent predictors of the need for ICU admission; and only CRP was significantly associated with the risk of in-hospital mortality. Yang and Co-workers [4] found that both NLR and PLR were independent predictors of disease severity and progression in their studied COVID-19 patients. Also, Fois and colleagues [9] found in their study that the SII was the only independent biomarker to predict in-hospital mortality of COVID-19 patients.

One limitation in our study was its retrospective design that could not keep up with the dynamic nature of the disease; more prospective studies with serial determination of biomarkers’ levels at different disease stages are still required for better definition of the cut off points that could predict the progression of the disease. our study was its retrospective design that could not keep up with the dynamic nature of the disease; more prospective studies with serial determination of biomarkers’ levels at different disease stages are still required for better definition of the cut off points that could predict the progression of the disease.

CONCLUSIONS

Elevated CRP, SII, and NLR were found to be independent prognostic biomarkers that could predict COVID-19 progression. The integration of CRP, SII, and NLR into prognostic nomograms may lead to improved prediction. While CRP along with other inflammatory markers like ESR, LDH, ferritin, and procalcitonin are frequently measured in COVID-19 patients, SII and NLR can be easily calculated using a differential CBC and are cost effective, especially for third world countries.

Funding sources

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Conflicts of interest

The authors declare that there is no conflict of interest regarding the ublication of this article.

Consent for publication

Not applicable.

Availability of data and materials

All data needed to support the current findings will be vailable upon request.

Author contributions

Sara I. Taha: conceptualization, methodology, software; Sara F. amaan and Aalaa K. Shata: investigation, data collection. Shereen A. Baioumy isualization, supervision. Mariam K. Youssef: writing-reviewing and editing, validation nd original draft preparation.